Kronox Lab Sciences Limited (NSE:KRONOX)

Market Cap	4.96B -3.4%
Revenue (ttm)	1.01B +1.0%
Net Income	276.60M +8.6%
EPS	7.51 +9.4%
Shares Out	37.10M
PE Ratio	17.81
Forward PE	n/a
Dividend	0.50 (0.38%)
Ex-Dividend Date	Aug 8, 2025

Volume	29,153
Open	134.00
Previous Close	133.15
Day's Range	131.82 - 134.86
52-Week Range	96.00 - 207.49
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 21, 2026

About Kronox Lab Sciences

Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custo...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2008
• Employees: 54
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KRONOX

Financial Performance

In fiscal year 2026, Kronox Lab Sciences's revenue was 1.01 billion, an increase of 1.02% compared to the previous year's 1.00 billion. Earnings were 276.60 million, an increase of 8.61%.